192 related articles for article (PubMed ID: 38598696)
41. Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile.
Phanchana M; Phetruen T; Harnvoravongchai P; Raksat P; Ounjai P; Chankhamhaengdecha S; Janvilisri T
Sci Rep; 2020 Apr; 10(1):6497. PubMed ID: 32300130
[TBL] [Abstract][Full Text] [Related]
42. Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
Putsathit P; Hong S; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
J Antimicrob Chemother; 2021 Jun; 76(7):1815-1821. PubMed ID: 33895826
[TBL] [Abstract][Full Text] [Related]
43. Fidaxomicin inhibits spore production in Clostridium difficile.
Babakhani F; Bouillaut L; Gomez A; Sears P; Nguyen L; Sonenshein AL
Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S162-9. PubMed ID: 22752866
[TBL] [Abstract][Full Text] [Related]
44. U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016.
Thorpe CM; McDermott LA; Tran MK; Chang J; Jenkins SG; Goldstein EJC; Patel R; Forbes BA; Johnson S; Gerding DN; Snydman DR
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31085514
[TBL] [Abstract][Full Text] [Related]
45. Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.
Karlowsky JA; Adam HJ; Baxter MR; Dutka CW; Nichol KA; Laing NM; Golding GR; Zhanel GG
J Antimicrob Chemother; 2020 Jul; 75(7):1824-1832. PubMed ID: 32294172
[TBL] [Abstract][Full Text] [Related]
46. The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients.
Krutova M; Capek V; Nycova E; Vojackova S; Balejova M; Geigerova L; Tejkalova R; Havlinova L; Vagnerova I; Cermak P; Ryskova L; Jezek P; Zamazalova D; Vesela D; Kucharova A; Nemcova D; Curdova M; Nyc O; Drevinek P
Antimicrob Resist Infect Control; 2020 Jun; 9(1):98. PubMed ID: 32605598
[TBL] [Abstract][Full Text] [Related]
47. Antimicrobial susceptibility of Clostridium difficile isolates in Israel.
Tkhawkho L; Nitzan O; Pastukh N; Brodsky D; Jackson K; Peretz A
J Glob Antimicrob Resist; 2017 Sep; 10():161-164. PubMed ID: 28729205
[TBL] [Abstract][Full Text] [Related]
48. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.
Nelson RL; Suda KJ; Evans CT
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD004610. PubMed ID: 28257555
[TBL] [Abstract][Full Text] [Related]
49. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.
Nicholas A; Kim YK; Lee WK; Selasi GN; Na SH; Kwon HI; Kim YJ; Lee HS; Song KE; Shin JH; Lee JC
PLoS One; 2017; 12(3):e0174716. PubMed ID: 28355266
[TBL] [Abstract][Full Text] [Related]
50. Prevalence, toxin gene profile, genotypes and antibiotic susceptibility of
Saber T; Hawash YA; Ismail KA; Khalifa AS; Alsharif KF; Alghamdi SA; Saber T; Eed EM
Indian J Med Microbiol; 2020; 38(2):176-182. PubMed ID: 32883931
[TBL] [Abstract][Full Text] [Related]
51. Changes in Clostridium (Clostridioides) difficile PCR-Ribotype Distribution and Antimicrobial Resistance in a German Tertiary Care Hospital Over the Last 10 Years.
Piepenbrock E; Stelzer Y; Berger F; Jazmati N
Curr Microbiol; 2019 Apr; 76(4):520-526. PubMed ID: 30805700
[TBL] [Abstract][Full Text] [Related]
52. Mechanisms and impact of antimicrobial resistance in Clostridioides difficile.
Dureja C; Olaitan AO; Hurdle JG
Curr Opin Microbiol; 2022 Apr; 66():63-72. PubMed ID: 35077947
[TBL] [Abstract][Full Text] [Related]
53. Fluoroquinolone resistance and Clostridium difficile, Germany.
Zaiss NH; Witte W; Nübel U
Emerg Infect Dis; 2010 Apr; 16(4):675-7. PubMed ID: 20350385
[TBL] [Abstract][Full Text] [Related]
54. Molecular epidemiology and antimicrobial resistance patterns of Clostridioides difficile isolates in Algerian hospitals.
Boudjelal Y; Krutova M; Djebbar A; Sebaihia M; Bekara MEA; Rouabhia S; Couturier J; Syed-Zaidi R; Barbut F
J Infect Dev Ctries; 2022 Jun; 16(6):1055-1063. PubMed ID: 35797301
[TBL] [Abstract][Full Text] [Related]
55. Defining the phylogenetics and resistome of the major
O'Grady K; Hong S; Putsathit P; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Levy A; Moore CV; Nimmo G; Prendergast L; Robson J; Speers DJ; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
Microb Genom; 2024 May; 10(5):. PubMed ID: 38717815
[No Abstract] [Full Text] [Related]
56. Molecular Characterization of, and Antimicrobial Resistance in,
Imwattana K; Putsathit P; Knight DR; Kiratisin P; Riley TV
Microb Drug Resist; 2021 Nov; 27(11):1505-1512. PubMed ID: 33956520
[TBL] [Abstract][Full Text] [Related]
57. Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
Gentry CA; Campbell DL; Williams RJ
Int J Antimicrob Agents; 2021 Mar; 57(3):106282. PubMed ID: 33465458
[TBL] [Abstract][Full Text] [Related]
58. Houston, We Have a Problem: Reports of Clostridioides difficile Isolates With Reduced Vancomycin Susceptibility.
Greentree DH; Rice LB; Donskey CJ
Clin Infect Dis; 2022 Oct; 75(9):1661-1664. PubMed ID: 35653393
[TBL] [Abstract][Full Text] [Related]
59. Molecular Epidemiology and Risk Factors of
Yang Z; Huang Q; Qin J; Zhang X; Jian Y; Lv H; Liu Q; Li M
Front Cell Infect Microbiol; 2020; 10():578098. PubMed ID: 33425775
[TBL] [Abstract][Full Text] [Related]
60. Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital.
Aspevall O; Lundberg A; Burman LG; Akerlund T; Svenungsson B
Antimicrob Agents Chemother; 2006 May; 50(5):1890-2. PubMed ID: 16641471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
